FDA approved spinal cord stimulators for chronic back pain
On May 16, 2023, the US Food and Drug Administration (FDA) approved spinal cord stimulation (SCS) devices from the pharmaceutical company Abbott for the treatment of chronic back pain in people who have not had or are not eligible for receiving back surgery, per a press release from Abbott. The approval was granted after a … Read more